0000899243-17-018643.txt : 20170720 0000899243-17-018643.hdr.sgml : 20170720 20170720170051 ACCESSION NUMBER: 0000899243-17-018643 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170718 FILED AS OF DATE: 20170720 DATE AS OF CHANGE: 20170720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MADDEN DAVID CENTRAL INDEX KEY: 0001230836 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36281 FILM NUMBER: 17974787 MAIL ADDRESS: STREET 1: ADOLOR CORP STREET 2: 700 PENNSYLVANIA DRIVE CITY: EXTON STATE: PA ZIP: 19431 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc CENTRAL INDEX KEY: 0001399529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617 621 8097 MAIL ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-18 0 0001399529 Dicerna Pharmaceuticals Inc DRNA 0001230836 MADDEN DAVID C/O DICERNA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 1 0 0 0 Director Stock Option (right to buy) 3.42 2017-07-18 4 A 0 33000 0.00 A 2027-07-18 Common Stock 33000 33000 D This option vests monthly over 12 months from July 11, 2017 in substantially equal monthly installments, subject to the Reporting Person's continued service to the Issuer through each such date. /s/ John B. Green, attorney-in-fact 2017-07-20